Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis

Figure 2

Analysis (nonparametric 𝑡-test for repeated measures) of the serum levels of IL-6, IL-8, and IL-22, as determined at baseline (T0) and after 24 weeks (T2) of therapy in all patients and in subgroups of subjects stratified according to the administration of the different anti-TNF-α drug regimens.